David Bramhill

President & Founder Bramhill Biologics Consulting

Dr. David Bramhill has over 25 years experience in engineering and producing biologics, including antibodies and scaffolds. He helped establish the Merck biologics department and has subsequently worked with numerous startup biotech companies and at a venture fund. He has experience in isolating and improving antibodies using phage display and other display systems, and is an inventor on library designs for small scaffolds. He has worked on ADCs and a series of related technologies. He also has experience in diverse expression systems for producing antibodies, antibody fragments and different scaffolds. He consults in business development and technology applications, and has taught numerous technical courses for over 15 years at international conferences.

Seminars

Monday 23rd February 2026
Check-In, Morning Coffee & Light Refreshments
8:30 am

If you’re a new entrant to the ADC field, join the ADC 101 day to brush up on your ADC knowledge ahead of the main scientific programme days.

As more companies enter the ever-growing antibody-drug conjugate field, this seminar day will provide you with the critical knowledge gained over years of research and failed clinical trials that’s culminated in the presently approved ADCs and booming innovation in the field.

Led by a long-standing expert and KOL in the field, join this one-stop-shop of ADC learning to establish a core understanding of the essential elements in ADC discovery and early development.

David Bramhill Speaker Photo - 16th World ADC London Summit